Physician profile
Taylor Kirkpatrick
NPI 1366072175
$10,152.72
in general payments reported to CMS, 2019-2025
24 companies · $8,005 in 2025
The $8,005 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $54.93 · 2023: $102 · 2024: $1,797 · 2025: $8,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,829 · Consulting Fee: $3,840 · Travel and Lodging: $1,036 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,828.90 |
| Consulting Fee | $3,840.00 |
| Travel and Lodging | $1,036.49 |
| Education | $198.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $5,701.31 | 2024-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $1,651.99 | 2024-2025 | Tremfya, Simponi Aria |
| Abbvie INC. | $503.94 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $463.95 | 2024-2025 | Acthar |
| Amgen INC. | $404.57 | 2024-2025 | Krystexxa, Uplizna, Tepezza |
| Lilly USA, LLC | $195.40 | 2024-2025 | Taltz, Omvoh |
| E.R. Squibb & Sons, L.L.C. | $177.93 | 2025 | Sotyktu, Orencia |
| Endo Pharmaceuticals INC. | $175.19 | 2021-2024 | Xiaflex |
| Ani Pharmaceuticals, INC. | $102.24 | 2025 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $101.11 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $89.54 | 2021-2023 | Euflexxa |
| Tersera Therapeutics LLC | $83.10 | 2025 | Quzyttir |
| Invivyd INC | $82.38 | 2025 | Pemgarda |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.67 | 2025 | |
| Fresenius Kabi USA, LLC | $75.96 | 2025 | Tyenne |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $50.05 | 2025 | Tymlos |
| Stryker Corporation | $35.18 | 2021 | |
| Organon LLC | $34.24 | 2025 | Hadlima, Renflexis |
| Actelion Pharmaceuticals US, INC. | $33.70 | 2024 | Uptravi |
| Bioventus LLC | $28.95 | 2021 | |
| Smith+Nephew, INC. | $28.58 | 2021 | |
| Pacira Therapeutics, INC. | $22.35 | 2021 | |
| Molnlycke Health Care US, LLC | $18.96 | 2022 | |
| Sobi, INC | $14.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Kirkpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.